Medifast, Inc. (NYSE:MED – Free Report) – Investment analysts at DA Davidson issued their Q1 2025 earnings per share estimates for Medifast in a report released on Thursday, February 20th. DA Davidson analyst L. Weiser expects that the specialty retailer will earn ($0.32) per share for the quarter. DA Davidson currently has a “Neutral” rating and a $16.50 target price on the stock. The consensus estimate for Medifast’s current full-year earnings is $0.51 per share. DA Davidson also issued estimates for Medifast’s FY2026 earnings at $0.50 EPS.
Medifast Trading Down 2.7 %
Shares of MED stock opened at $14.38 on Monday. The stock has a market cap of $157.24 million, a price-to-earnings ratio of 79.87 and a beta of 1.14. The stock has a 50-day moving average of $16.00 and a 200-day moving average of $17.82. Medifast has a 1-year low of $13.57 and a 1-year high of $42.68.
Institutional Investors Weigh In On Medifast
Several large investors have recently added to or reduced their stakes in MED. Wells Fargo & Company MN grew its stake in Medifast by 23.5% during the fourth quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer’s stock worth $114,000 after purchasing an additional 1,227 shares during the period. Quarry LP boosted its holdings in Medifast by 148.6% in the third quarter. Quarry LP now owns 6,629 shares of the specialty retailer’s stock worth $127,000 after acquiring an additional 3,962 shares in the last quarter. Public Employees Retirement System of Ohio boosted its holdings in Medifast by 1,161.8% in the third quarter. Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer’s stock worth $187,000 after acquiring an additional 8,992 shares in the last quarter. State of Wyoming boosted its holdings in Medifast by 286.1% in the fourth quarter. State of Wyoming now owns 11,312 shares of the specialty retailer’s stock worth $199,000 after acquiring an additional 8,382 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its holdings in Medifast by 2,308.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer’s stock worth $202,000 after acquiring an additional 10,967 shares in the last quarter. Institutional investors and hedge funds own 95.51% of the company’s stock.
Medifast Company Profile
Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.
Featured Stories
- Five stocks we like better than Medifast
- What is a SEC Filing?
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Should You Invest in Penny Stocks?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.